Search Results - "Funck Brentano, E"

Impact of the French COVID‐19 pandemic lockdown on newly diagnosed melanoma delay and severity by Molinier, R., Roger, A., Genet, B., Blom, A., Longvert, C., Chaplain, L., Fort, M., Saiag, P., Funck‐Brentano, E.

Get full text

Second primary cutaneous melanoma in patients with advanced melanoma treated with anti‐programmed‐death‐receptor‐1 monoclonal antibodies by Charvet, E., Kramkimel, N., Chaplain, L., Gantzer, A., Kassem, O., Longvert, C., Blom, A., Dupin, N., Aractingi, S., Hamon, M., Zimmermann, U., Emile, J.‐F., Sohier, P., Sidibé, T., Saiag, P., Funck‐Brentano, E.

Get full text

Formalin‐fixed tissue Mohs surgery (slow Mohs) for trichoblastic carcinoma by Gonzalez‐Lara, L., Bonsang, B., Zimmermann, U., Blom, A., Chapalain, M., Tchakerian, A., Serra, M., Aouidad, I., Chaplain, L., Roger, A., Longvert, C., Saiag, P., Funck‐Brentano, E.

Get full text

Monitoring of plasma concentrations of dabrafenib and trametinib in advanced BRAFV600mut melanoma patients by Raynal, M., Alvarez, J.-C., Saiag, P., Beauchet, A., Funck-Brentano, C., Funck-Brentano, E.

“…Dabrafenib (D) and trametinib (T) improved survival in patients with BRAFV600mut melanoma. High plasma concentration of D (PCD) is weakly associated with…”
Get full text

Which adjuvant treatment for patients with BRAFV600-mutant cutaneous melanoma? by Funck-Brentano, E., Malissen, N., Roger, A., Lebbé, C., Deilhes, F., Frénard, C., Dréno, B., Meyer, N., Grob, J.-J., Tétu, P., Saiag, P.

“…Treatment of patients with melanoma has considerably improved over the past decade and more recently with adjuvant therapies for patients with American Joint…”
Get full text

Reply to the letter to the editor ‘Plasma vemurafenib concentrations in advanced BRAFV600mut melanoma patients: impact on tumor response and tolerance’ by Funck-Brentano et al by Funck-Brentano, E., Alvarez, J.C., Longvert, C., Abe, E., Beauchet, A., Saiag, P., Funck-Brentano, C.

Get full text

Plasma vemurafenib concentrations in advanced BRAFV600mut melanoma patients: impact on tumour response and tolerance by Funck-Brentano, E., Alvarez, J.C., Longvert, C., Abe, E., Beauchet, A., Funck-Brentano, C., Saiag, P.

“…Vemurafenib improves survival in advanced BRAFV600mut melanoma patients, but tolerance is often poor and resistance frequently occurs, without predictive…”
Get full text

Nodular cutaneous amyloidosis associated with Sjögren's syndrome by Elfatoiki, F Z, Funck Brentano, E, Blanc, F, Clerici, T, Saiag, P

“…Cutaneous nodular amyloidosis is rare, and association with Sjögren's syndrome has been reported. We discuss the possible link between these two diseases based…”
Get full text

Auto-immune thyroiditis and drug reaction with eosinophilia and systemic symptoms (DRESS) associated with HHV-6 viral reactivation by Funck-Brentano, E, Duong, T, Family, D, Bouaziz, J-D, Ortonne, N, Bagot, M, Roujeau, J-C, Wolkenstein, P, Valeyrie-Allanore, L

“…DRESS syndrome is a severe adverse drug reaction with visceral involvement. Its physiopathology includes immunological disorders associated with human herpes…”
Get full text

1068P Efficacy of combined hypo-fractionated radiotherapy (RT) in anti-PD-1 monotherapy-treated melanoma pts by Saiag, P., Molinier, R., Roger, A., Boru, B., Otmezguine, Y., Otz, J., Valery, C., Blom Fily, A., Longvert, C., Beauchet, A., Funck-Brentano, E.

Get full text

Monitoring of plasma concentrations of dabrafenib and trametinib in advanced BRAFV600 mut melanoma patients by Raynal, M, Alvarez, J-C, Saiag, P, Beauchet, A, Funck-Brentano, C, Funck-Brentano, E

“…Dabrafenib (D) and trametinib (T) improved survival in patients with BRAFV600 melanoma. High plasma concentration of D (PCD) is weakly associated with adverse…”
Get full text

Thyroïdite auto-immune et syndrome d’hypersensibilité médicamenteuse (DRESS) associés à une réactivation virale HHV6 by Funck-Brentano, E., Duong, T., Family, D., Bouaziz, J.-D., Ortonne, N., Bagot, M., Roujeau, J.-C., Wolkenstein, P., Valeyrie-Allanore, L.

“…Le syndrome d’hypersensibilité médicamenteuse ou drug reaction with eosinophilia and systemic symptoms (DRESS) est une toxidermie sévère dont la…”
Get full text

Monitoring of plasma concentrations of dabrafenib and trametinib in advanced BRAFV600 melanoma patients by Raynal, M., Alvarez, J.-C., Saiag, P., Beauchet, A., Funck-Brentano, C., Funck-Brentano, E.

Get full text

Prognostic Value of 25-hydroxyvitamin D3 Levels at Diagnosis and During Follow-up in Melanoma Patients by Saiag, Philippe, Aegerter, Philippe, Vitoux, Dominique, Lebbé, Celeste, Wolkenstein, Pierre, Dupin, Nicolas, Descamps, Vincent, Aractingi, Selim, Funck-Brentano, Elisa, Autier, Philippe, Dragomir, Miruna, Boniol, Mathieu

“…A low 25-hydroxyvitamin D3 (25(OH)D3) serum concentration at melanoma diagnosis might be associated with worse survival. We prospectively studied the…”
Get full text

A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma by Einarsdottir, Berglind O., Karlsson, Joakim, Söderberg, Elin M. V., Lindberg, Mattias F., Funck-Brentano, Elisa, Jespersen, Henrik, Brynjolfsson, Siggeir F., Olofsson Bagge, Roger, Carstam, Louise, Scobie, Martin, Koolmeister, Tobias, Wallner, Olof, Stierner, Ulrika, Berglund, Ulrika Warpman, Ny, Lars, Nilsson, Lisa M., Larsson, Erik, Helleday, Thomas, Nilsson, Jonas A.

“…Karonudib (TH1579) is a novel compound that exerts anti-tumor activities and has recently entered phase I clinical testing. The aim of this study was to…”
Get full text

Re: High nevus counts confer a favorable prognosis in melanoma patients by S ribero and co‐workers, published in the International Journal of Cancer, 2015 (online 21 march 2015) by Autier, Philippe, Funck‐Brentano, Elisa, Aegerter, Philippe, Boniol, Mathieu, Saiag, Philippe

Get full text

Correction: A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma by Einarsdottir, Berglind O., Karlsson, Joakim, Söderberg, Elin M. V., Lindberg, Mattias F., Funck-Brentano, Elisa, Jespersen, Henrik, Brynjolfsson, Siggeir F., Bagge, Roger Olofsson, Carstam, Louise, Scobie, Martin, Koolmeister, Tobias, Wallner, Olof, Stierner, Ulrika, Berglund, Ulrika Warpman, Ny, Lars, Nilsson, Lisa M., Larsson, Erik, Helleday, Thomas, Nilsson, Jonas A.

“…On Pubmed, the name of co-author Roger Olofsson Bagge appeared incorrectly as “Bagge RO” instead of “Olofsson Bagge, Roger”. This has been corrected in the PDF…”
Get full text

Relation entre concentrations plasmatiques de dabrafénib (D) et tramétinib (T), contrôle du mélanome avancé, et effets indésirables (EI) by Raynal, M., Saiag, P., Alvarez, J.-C., Beauchet, A., Funck-Brentano, C., Funck-Brentano, E.

“…L’association D+T est un traitement majeur des mélanomes avancés mutés BRAFV600 avec un risque d’échappement et d’EI. Nous avons recherché un lien entre…”
Get full text

Impact de l’immunothérapie sur l’efficacité de la dacarbazine dans le mélanome métastatique by Bouchereau, S., Chaplain, L., Fort, M., Beauchet, A., Sidibé, T., Chapalain, M., Gonzalez-Lara, L., Longvert, C., Blom, A., Aouidad, I., Saiag, P., Funck-Brentano, E.

“…Quelques observations ont suggéré une meilleure efficacité des chimiothérapies chez des patients avec un mélanome ou un cancer du poumon traités au préalable…”
Get full text

Carcinomes trichoblastiques traités par chirurgie micrographique en paraffine by Gonzalez Lara, L., Funck-Brentano, E., Bonsang, B., Zimmermann, U., Blom, A., Chapalain, M., Tchakerien, A., Serra, M., Aouidad, I., Chaplain, L., Roger, A., Longvert, C., Saiag, P.

“…Le carcinome trichoblastique (CT) est une tumeur annexielle maligne rare. Le traitement standard est chirurgical ; cependant, dans 2/3 des cas des reprises…”
Get full text